Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Tranexamic Acid for Melasma
NCT05236569Completed
- Sponsor
- Universitas Indonesia
- Start
- Feb 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in melasma comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Modified Melasma Area and Severity Index at 12 weeks, Erythema Index at 12 weeks and 1 more. Started Feb 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT05236569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05236569.